Sugar-sweetened beverage intake and cancer recurrence and survival in CALGB 89803 (Alliance) Journal Article


Authors: Fuchs, M. A.; Sato, K.; Niedzwiecki, D.; Ye, X.; Saltz, L. B.; Mayer, R. J.; Mowat, R. B.; Whittom, R.; Hantel, A.; Benson, A.; Atienza, D.; Messino, M.; Kindler, H.; Venook, A.; Ogino, S.; Wu, K.; Willett, W. C.; Giovannucci, E. L.; Meyerhardt, J. A.
Article Title: Sugar-sweetened beverage intake and cancer recurrence and survival in CALGB 89803 (Alliance)
Abstract: Background: In colon cancer patients, obesity, sedentary lifestyle, and high dietary glycemic load have been associated with increased risk of cancer recurrence. High sugar-sweetened beverage intake has been associated with obesity, diabetes, and cardio-metabolic diseases, but the influence on colon cancer survival is unknown. Methods: We assessed the association between sugar-sweetened beverage consumption on cancer recurrence and mortality in 1,011 stage III colon cancer patients who completed food frequency questionnaires as part of a U.S. National Cancer Institute-sponsored adjuvant chemotherapy trial. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated with Cox proportional hazard models. Results: Patients consuming ≥2 servings of sugar-sweetened beverages per day experienced an adjusted HR for disease recurrence or mortality of 1.67 (95% CI, 1.04-2.68), compared with those consuming <2 servings per month (Ptrend = 0.02). The association of sugar-sweetened beverages on cancer recurrence or mortality appeared greater among patients who were both overweight (body mass index ≥25 kg/m 2) and less physically active (metabolic equivalent task-hours per week < 18) (HR = 2.22; 95% CI, 1.29-3.81, Ptrend = 0.0025). Conclusion: Higher sugar-sweetened beverage intake was associated with a significantly increased risk of cancer recurrence and mortality in stage III colon cancer patients. © 2014 Fuchs et al.
Keywords: adult; cancer survival; controlled study; aged; major clinical study; cancer recurrence; fluorouracil; cancer risk; cancer adjuvant therapy; cancer patient; cancer staging; prospective study; disease association; controlled clinical trial; cohort analysis; obesity; food intake; cancer mortality; irinotecan; diet; body mass; food frequency questionnaire; proportional hazards model; folinic acid; colon cancer; physical activity; hazard ratio; lifestyle; sugar; beverage; metabolic equivalent; very elderly; human; male; female; article; sugar sweetened beverage
Journal Title: PLoS ONE
Volume: 9
Issue: 6
ISSN: 1932-6203
Publisher: Public Library of Science  
Date Published: 2014-06-17
Start Page: e99816
Language: English
DOI: 10.1371/journal.pone.0099816
PROVIDER: scopus
PMCID: PMC4061031
PUBMED: 24937507
DOI/URL:
Notes: Export Date: 1 August 2014 -- CODEN: POLNC -- Source: Scopus
Altmetric
Citation Impact
MSK Authors
  1. Leonard B Saltz
    761 Saltz